Ban on Krka's Sales of Donepezil in Norway Lifted

Ljubljana, 13 March - The Swedish subsidiary of the Slovenian generics maker Krka will start marketing Donepezil in Norway after the High Court in Oslo has annulled a temporary ban due to patent violation, according to Friday's press release from Krka.